Down -8.63% in 4 Weeks, Here's Why You Should You Buy the Dip in IDEAYA Biosciences (IDYA)
Portfolio Pulse from
IDEAYA Biosciences (IDYA) has experienced a significant drop of 8.63% over the past four weeks, but it is now considered oversold. Wall Street analysts are revising earnings estimates higher, suggesting a potential trend reversal.
February 14, 2025 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IDEAYA Biosciences has seen a significant price drop, but technical indicators and analyst sentiment suggest a potential rebound. The stock is in oversold territory, and earnings estimates are being revised upwards.
The stock's recent decline of 8.63% has pushed it into oversold territory, a technical indicator suggesting a potential price rebound. Additionally, the upward revision of earnings estimates by analysts supports the likelihood of a positive trend reversal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100